PDB Short entry for 2O8Y HEADER TRANSFERASE 12-DEC-06 2O8Y TITLE APO IRAK4 KINASE DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: IRAK4 KINASE DOMAIN; COMPND 5 SYNONYM: IRAK-4, NY- REN-64 ANTIGEN; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IRAK4; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: VIRUS; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PFASTBAC HTA KEYWDS PROTEIN KINASE, IMMUNODEFICIENCY, INFLAMMATION, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR P.A.BORIACK-SJODIN,C.MOL REVDAT 3 27-DEC-23 2O8Y 1 SEQADV LINK REVDAT 2 24-FEB-09 2O8Y 1 VERSN REVDAT 1 25-DEC-07 2O8Y 0 JRNL AUTH C.D.MOL,R.M.ARDUINI,D.P.BAKER,E.Y.CHIEN,D.R.DOUGAN, JRNL AUTH 2 J.FRIEDMAN,V.GIBAJA,C.A.HESSION,A.HORNE JRNL TITL CRYSTAL STRUCTURES OF THE APO AND INHIBITED IRAK4 KINASE JRNL TITL 2 DOMAIN JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 29503 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.244 REMARK 3 FREE R VALUE : 0.289 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1448 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 28 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.43 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 848 REMARK 3 BIN R VALUE (WORKING SET) : 0.3300 REMARK 3 BIN FREE R VALUE : 0.3740 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 47 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4398 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 59 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.91 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.42200 REMARK 3 B22 (A**2) : -1.50800 REMARK 3 B33 (A**2) : 9.93100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.515 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.567 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.154 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.199 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_TPO.PARAM REMARK 3 PARAMETER FILE 2 : MSI_CNX_TOPPAR:WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2O8Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-DEC-06. REMARK 100 THE DEPOSITION ID IS D_1000040836. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29503 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.09100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.50 REMARK 200 COMPLETENESS FOR SHELL (%) : 85.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.30 REMARK 200 R MERGE FOR SHELL (I) : 0.46600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SHELXS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.77 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1 UL PROTEIN(14.5 MG/ML IN 50 MM TRIS REMARK 280 -HCL PH 7.6, 250 MM NACL, 250 MM TCEP, AND 100 MM EDTA REMARK 280 SUPPLEMENTED WITH 2 MM ADP AND 4 MM MGCL2 PRIOR TO REMARK 280 CRYSTALLIZATION) AND 1 UL OF RESERVOIR SOLUTION (100 MM HEPES PH REMARK 280 7.5, 20-25% PEG 3350, 200 MM AMMONIUM SULFATE), VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 45.07500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 59.32000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 70.35500 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 45.07500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 59.32000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 70.35500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 45.07500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 59.32000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 70.35500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 45.07500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 59.32000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 70.35500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 163 REMARK 465 ARG A 164 REMARK 465 ALA A 216 REMARK 465 ALA A 217 REMARK 465 MET A 218 REMARK 465 VAL A 219 REMARK 465 ASP A 220 REMARK 465 ILE A 221 REMARK 465 THR A 222 REMARK 465 THR A 223 REMARK 465 GLU A 224 REMARK 465 GLU A 225 REMARK 465 GLU A 337 REMARK 465 LYS A 338 REMARK 465 PHE A 339 REMARK 465 ALA A 340 REMARK 465 GLN A 341 REMARK 465 SER A 460 REMARK 465 THR B 163 REMARK 465 ARG B 164 REMARK 465 SER B 186 REMARK 465 VAL B 187 REMARK 465 GLY B 188 REMARK 465 ALA B 216 REMARK 465 ALA B 217 REMARK 465 MET B 218 REMARK 465 VAL B 219 REMARK 465 ASP B 220 REMARK 465 ILE B 221 REMARK 465 THR B 222 REMARK 465 THR B 223 REMARK 465 GLU B 224 REMARK 465 GLU B 225 REMARK 465 LEU B 226 REMARK 465 GLU B 337 REMARK 465 LYS B 338 REMARK 465 PHE B 339 REMARK 465 ALA B 340 REMARK 465 SER B 460 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 194 -148.66 -140.51 REMARK 500 PHE A 197 -53.58 -17.00 REMARK 500 ASN A 207 -8.15 69.12 REMARK 500 ASP A 256 -93.96 -71.68 REMARK 500 ARG A 310 -5.87 76.47 REMARK 500 ASP A 311 42.21 -145.06 REMARK 500 ASP A 329 84.30 66.07 REMARK 500 GLU A 406 32.88 38.03 REMARK 500 LYS A 417 42.53 -94.17 REMARK 500 PHE B 180 60.87 74.12 REMARK 500 ASP B 254 -167.97 -63.89 REMARK 500 ASN B 305 34.27 -96.83 REMARK 500 ASP B 311 44.15 -150.51 REMARK 500 ASP B 320 -159.66 -87.70 REMARK 500 ASP B 329 89.29 62.43 REMARK 500 ASP B 388 117.81 -161.84 REMARK 500 HIS B 390 47.02 -104.59 REMARK 500 ASP B 405 20.45 -74.88 REMARK 500 GLU B 406 26.93 43.41 REMARK 500 LYS B 417 38.29 -90.92 REMARK 500 ASN B 419 23.70 -159.02 REMARK 500 REMARK 500 REMARK: NULL DBREF 2O8Y A 163 460 UNP Q9NWZ3 IRAK4_HUMAN 163 460 DBREF 2O8Y B 163 460 UNP Q9NWZ3 IRAK4_HUMAN 163 460 SEQADV 2O8Y MSE A 192 UNP Q9NWZ3 MET 192 MODIFIED RESIDUE SEQADV 2O8Y MSE A 237 UNP Q9NWZ3 MET 237 MODIFIED RESIDUE SEQADV 2O8Y MSE A 265 UNP Q9NWZ3 MET 265 MODIFIED RESIDUE SEQADV 2O8Y MSE A 287 UNP Q9NWZ3 MET 287 MODIFIED RESIDUE SEQADV 2O8Y TPO A 342 UNP Q9NWZ3 THR 342 MODIFIED RESIDUE SEQADV 2O8Y MSE A 344 UNP Q9NWZ3 MET 344 MODIFIED RESIDUE SEQADV 2O8Y TPO A 345 UNP Q9NWZ3 THR 345 MODIFIED RESIDUE SEQADV 2O8Y MSE A 355 UNP Q9NWZ3 MET 355 MODIFIED RESIDUE SEQADV 2O8Y MSE A 418 UNP Q9NWZ3 MET 418 MODIFIED RESIDUE SEQADV 2O8Y MSE A 429 UNP Q9NWZ3 MET 429 MODIFIED RESIDUE SEQADV 2O8Y MSE A 457 UNP Q9NWZ3 MET 457 MODIFIED RESIDUE SEQADV 2O8Y MSE B 192 UNP Q9NWZ3 MET 192 MODIFIED RESIDUE SEQADV 2O8Y MSE B 237 UNP Q9NWZ3 MET 237 MODIFIED RESIDUE SEQADV 2O8Y MSE B 265 UNP Q9NWZ3 MET 265 MODIFIED RESIDUE SEQADV 2O8Y MSE B 287 UNP Q9NWZ3 MET 287 MODIFIED RESIDUE SEQADV 2O8Y TPO B 342 UNP Q9NWZ3 THR 342 MODIFIED RESIDUE SEQADV 2O8Y MSE B 344 UNP Q9NWZ3 MET 344 MODIFIED RESIDUE SEQADV 2O8Y TPO B 345 UNP Q9NWZ3 THR 345 MODIFIED RESIDUE SEQADV 2O8Y MSE B 355 UNP Q9NWZ3 MET 355 MODIFIED RESIDUE SEQADV 2O8Y MSE B 418 UNP Q9NWZ3 MET 418 MODIFIED RESIDUE SEQADV 2O8Y MSE B 429 UNP Q9NWZ3 MET 429 MODIFIED RESIDUE SEQADV 2O8Y MSE B 457 UNP Q9NWZ3 MET 457 MODIFIED RESIDUE SEQRES 1 A 298 THR ARG PHE HIS SER PHE SER PHE TYR GLU LEU LYS ASN SEQRES 2 A 298 VAL THR ASN ASN PHE ASP GLU ARG PRO ILE SER VAL GLY SEQRES 3 A 298 GLY ASN LYS MSE GLY GLU GLY GLY PHE GLY VAL VAL TYR SEQRES 4 A 298 LYS GLY TYR VAL ASN ASN THR THR VAL ALA VAL LYS LYS SEQRES 5 A 298 LEU ALA ALA MET VAL ASP ILE THR THR GLU GLU LEU LYS SEQRES 6 A 298 GLN GLN PHE ASP GLN GLU ILE LYS VAL MSE ALA LYS CYS SEQRES 7 A 298 GLN HIS GLU ASN LEU VAL GLU LEU LEU GLY PHE SER SER SEQRES 8 A 298 ASP GLY ASP ASP LEU CYS LEU VAL TYR VAL TYR MSE PRO SEQRES 9 A 298 ASN GLY SER LEU LEU ASP ARG LEU SER CYS LEU ASP GLY SEQRES 10 A 298 THR PRO PRO LEU SER TRP HIS MSE ARG CYS LYS ILE ALA SEQRES 11 A 298 GLN GLY ALA ALA ASN GLY ILE ASN PHE LEU HIS GLU ASN SEQRES 12 A 298 HIS HIS ILE HIS ARG ASP ILE LYS SER ALA ASN ILE LEU SEQRES 13 A 298 LEU ASP GLU ALA PHE THR ALA LYS ILE SER ASP PHE GLY SEQRES 14 A 298 LEU ALA ARG ALA SER GLU LYS PHE ALA GLN TPO VAL MSE SEQRES 15 A 298 TPO SER ARG ILE VAL GLY THR THR ALA TYR MSE ALA PRO SEQRES 16 A 298 GLU ALA LEU ARG GLY GLU ILE THR PRO LYS SER ASP ILE SEQRES 17 A 298 TYR SER PHE GLY VAL VAL LEU LEU GLU ILE ILE THR GLY SEQRES 18 A 298 LEU PRO ALA VAL ASP GLU HIS ARG GLU PRO GLN LEU LEU SEQRES 19 A 298 LEU ASP ILE LYS GLU GLU ILE GLU ASP GLU GLU LYS THR SEQRES 20 A 298 ILE GLU ASP TYR ILE ASP LYS LYS MSE ASN ASP ALA ASP SEQRES 21 A 298 SER THR SER VAL GLU ALA MSE TYR SER VAL ALA SER GLN SEQRES 22 A 298 CYS LEU HIS GLU LYS LYS ASN LYS ARG PRO ASP ILE LYS SEQRES 23 A 298 LYS VAL GLN GLN LEU LEU GLN GLU MSE THR ALA SER SEQRES 1 B 298 THR ARG PHE HIS SER PHE SER PHE TYR GLU LEU LYS ASN SEQRES 2 B 298 VAL THR ASN ASN PHE ASP GLU ARG PRO ILE SER VAL GLY SEQRES 3 B 298 GLY ASN LYS MSE GLY GLU GLY GLY PHE GLY VAL VAL TYR SEQRES 4 B 298 LYS GLY TYR VAL ASN ASN THR THR VAL ALA VAL LYS LYS SEQRES 5 B 298 LEU ALA ALA MET VAL ASP ILE THR THR GLU GLU LEU LYS SEQRES 6 B 298 GLN GLN PHE ASP GLN GLU ILE LYS VAL MSE ALA LYS CYS SEQRES 7 B 298 GLN HIS GLU ASN LEU VAL GLU LEU LEU GLY PHE SER SER SEQRES 8 B 298 ASP GLY ASP ASP LEU CYS LEU VAL TYR VAL TYR MSE PRO SEQRES 9 B 298 ASN GLY SER LEU LEU ASP ARG LEU SER CYS LEU ASP GLY SEQRES 10 B 298 THR PRO PRO LEU SER TRP HIS MSE ARG CYS LYS ILE ALA SEQRES 11 B 298 GLN GLY ALA ALA ASN GLY ILE ASN PHE LEU HIS GLU ASN SEQRES 12 B 298 HIS HIS ILE HIS ARG ASP ILE LYS SER ALA ASN ILE LEU SEQRES 13 B 298 LEU ASP GLU ALA PHE THR ALA LYS ILE SER ASP PHE GLY SEQRES 14 B 298 LEU ALA ARG ALA SER GLU LYS PHE ALA GLN TPO VAL MSE SEQRES 15 B 298 TPO SER ARG ILE VAL GLY THR THR ALA TYR MSE ALA PRO SEQRES 16 B 298 GLU ALA LEU ARG GLY GLU ILE THR PRO LYS SER ASP ILE SEQRES 17 B 298 TYR SER PHE GLY VAL VAL LEU LEU GLU ILE ILE THR GLY SEQRES 18 B 298 LEU PRO ALA VAL ASP GLU HIS ARG GLU PRO GLN LEU LEU SEQRES 19 B 298 LEU ASP ILE LYS GLU GLU ILE GLU ASP GLU GLU LYS THR SEQRES 20 B 298 ILE GLU ASP TYR ILE ASP LYS LYS MSE ASN ASP ALA ASP SEQRES 21 B 298 SER THR SER VAL GLU ALA MSE TYR SER VAL ALA SER GLN SEQRES 22 B 298 CYS LEU HIS GLU LYS LYS ASN LYS ARG PRO ASP ILE LYS SEQRES 23 B 298 LYS VAL GLN GLN LEU LEU GLN GLU MSE THR ALA SER MODRES 2O8Y MSE A 192 MET SELENOMETHIONINE MODRES 2O8Y MSE A 237 MET SELENOMETHIONINE MODRES 2O8Y MSE A 265 MET SELENOMETHIONINE MODRES 2O8Y MSE A 287 MET SELENOMETHIONINE MODRES 2O8Y TPO A 342 THR PHOSPHOTHREONINE MODRES 2O8Y MSE A 344 MET SELENOMETHIONINE MODRES 2O8Y TPO A 345 THR PHOSPHOTHREONINE MODRES 2O8Y MSE A 355 MET SELENOMETHIONINE MODRES 2O8Y MSE A 418 MET SELENOMETHIONINE MODRES 2O8Y MSE A 429 MET SELENOMETHIONINE MODRES 2O8Y MSE A 457 MET SELENOMETHIONINE MODRES 2O8Y MSE B 192 MET SELENOMETHIONINE MODRES 2O8Y MSE B 237 MET SELENOMETHIONINE MODRES 2O8Y MSE B 265 MET SELENOMETHIONINE MODRES 2O8Y MSE B 287 MET SELENOMETHIONINE MODRES 2O8Y TPO B 342 THR PHOSPHOTHREONINE MODRES 2O8Y MSE B 344 MET SELENOMETHIONINE MODRES 2O8Y TPO B 345 THR PHOSPHOTHREONINE MODRES 2O8Y MSE B 355 MET SELENOMETHIONINE MODRES 2O8Y MSE B 418 MET SELENOMETHIONINE MODRES 2O8Y MSE B 429 MET SELENOMETHIONINE MODRES 2O8Y MSE B 457 MET SELENOMETHIONINE HET MSE A 192 8 HET MSE A 237 8 HET MSE A 265 8 HET MSE A 287 8 HET TPO A 342 11 HET MSE A 344 8 HET TPO A 345 11 HET MSE A 355 8 HET MSE A 418 8 HET MSE A 429 8 HET MSE A 457 8 HET MSE B 192 8 HET MSE B 237 8 HET MSE B 265 8 HET MSE B 287 8 HET TPO B 342 11 HET MSE B 344 8 HET TPO B 345 11 HET MSE B 355 8 HET MSE B 418 8 HET MSE B 429 8 HET MSE B 457 8 HETNAM MSE SELENOMETHIONINE HETNAM TPO PHOSPHOTHREONINE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 MSE 18(C5 H11 N O2 SE) FORMUL 1 TPO 4(C4 H10 N O6 P) FORMUL 3 HOH *59(H2 O) HELIX 1 1 SER A 169 THR A 177 1 9 HELIX 2 2 PRO A 184 GLY A 188 5 5 HELIX 3 3 LEU A 226 MSE A 237 1 12 HELIX 4 4 ALA A 238 CYS A 240 5 3 HELIX 5 5 SER A 269 SER A 275 1 7 HELIX 6 6 CYS A 276 THR A 280 5 5 HELIX 7 7 SER A 284 ASN A 305 1 22 HELIX 8 8 LYS A 313 ALA A 315 5 3 HELIX 9 9 THR A 351 MSE A 355 5 5 HELIX 10 10 ALA A 356 ARG A 361 1 6 HELIX 11 11 THR A 365 GLY A 383 1 19 HELIX 12 12 LEU A 395 LEU A 397 5 3 HELIX 13 13 ASP A 398 ASP A 405 1 8 HELIX 14 14 THR A 409 ILE A 414 1 6 HELIX 15 15 ASP A 422 LEU A 437 1 16 HELIX 16 16 LYS A 440 ARG A 444 5 5 HELIX 17 17 ASP A 446 ALA A 459 1 14 HELIX 18 18 SER B 169 THR B 177 1 9 HELIX 19 19 LYS B 227 CYS B 240 1 14 HELIX 20 20 SER B 269 SER B 275 1 7 HELIX 21 21 CYS B 276 THR B 280 5 5 HELIX 22 22 SER B 284 ASN B 305 1 22 HELIX 23 23 LYS B 313 ALA B 315 5 3 HELIX 24 24 THR B 351 MSE B 355 5 5 HELIX 25 25 ALA B 356 GLY B 362 1 7 HELIX 26 26 PRO B 366 GLY B 383 1 18 HELIX 27 27 LEU B 395 LEU B 397 5 3 HELIX 28 28 ASP B 398 ASP B 405 1 8 HELIX 29 29 THR B 409 ILE B 414 1 6 HELIX 30 30 ASP B 422 LEU B 437 1 16 HELIX 31 31 LYS B 440 ARG B 444 5 5 HELIX 32 32 ASP B 446 THR B 458 1 13 SHEET 1 A 6 HIS A 166 SER A 167 0 SHEET 2 A 6 LEU A 248 SER A 252 1 O PHE A 251 N HIS A 166 SHEET 3 A 6 CYS A 259 VAL A 263 -1 O VAL A 261 N GLY A 250 SHEET 4 A 6 THR A 208 LYS A 214 -1 N LYS A 213 O LEU A 260 SHEET 5 A 6 VAL A 200 VAL A 205 -1 N TYR A 201 O VAL A 212 SHEET 6 A 6 LYS A 191 GLY A 193 -1 N MSE A 192 O VAL A 200 SHEET 1 B 2 HIS A 307 ILE A 308 0 SHEET 2 B 2 ARG A 334 ALA A 335 -1 O ARG A 334 N ILE A 308 SHEET 1 C 2 ILE A 317 LEU A 319 0 SHEET 2 C 2 ALA A 325 ILE A 327 -1 O LYS A 326 N LEU A 318 SHEET 1 D 2 VAL A 343 MSE A 344 0 SHEET 2 D 2 GLU A 363 ILE A 364 -1 O ILE A 364 N VAL A 343 SHEET 1 E 6 HIS B 166 SER B 167 0 SHEET 2 E 6 LEU B 248 SER B 252 1 O PHE B 251 N HIS B 166 SHEET 3 E 6 LEU B 258 VAL B 263 -1 O VAL B 261 N GLY B 250 SHEET 4 E 6 THR B 209 LEU B 215 -1 N LYS B 213 O LEU B 260 SHEET 5 E 6 VAL B 199 TYR B 204 -1 N GLY B 203 O VAL B 210 SHEET 6 E 6 LYS B 191 GLY B 193 -1 N MSE B 192 O VAL B 200 SHEET 1 F 2 HIS B 307 ILE B 308 0 SHEET 2 F 2 ARG B 334 ALA B 335 -1 O ARG B 334 N ILE B 308 SHEET 1 G 2 ILE B 317 LEU B 319 0 SHEET 2 G 2 ALA B 325 ILE B 327 -1 O LYS B 326 N LEU B 318 SHEET 1 H 2 VAL B 343 MSE B 344 0 SHEET 2 H 2 GLU B 363 ILE B 364 -1 O ILE B 364 N VAL B 343 LINK C LYS A 191 N MSE A 192 1555 1555 1.33 LINK C MSE A 192 N GLY A 193 1555 1555 1.33 LINK C VAL A 236 N MSE A 237 1555 1555 1.33 LINK C MSE A 237 N ALA A 238 1555 1555 1.33 LINK C TYR A 264 N MSE A 265 1555 1555 1.33 LINK C MSE A 265 N PRO A 266 1555 1555 1.34 LINK C HIS A 286 N MSE A 287 1555 1555 1.32 LINK C MSE A 287 N ARG A 288 1555 1555 1.33 LINK C TPO A 342 N VAL A 343 1555 1555 1.33 LINK C VAL A 343 N MSE A 344 1555 1555 1.33 LINK C MSE A 344 N TPO A 345 1555 1555 1.33 LINK C TPO A 345 N SER A 346 1555 1555 1.33 LINK C TYR A 354 N MSE A 355 1555 1555 1.32 LINK C MSE A 355 N ALA A 356 1555 1555 1.33 LINK C LYS A 417 N MSE A 418 1555 1555 1.33 LINK C MSE A 418 N ASN A 419 1555 1555 1.33 LINK C ALA A 428 N MSE A 429 1555 1555 1.34 LINK C MSE A 429 N TYR A 430 1555 1555 1.33 LINK C GLU A 456 N MSE A 457 1555 1555 1.33 LINK C MSE A 457 N THR A 458 1555 1555 1.33 LINK C LYS B 191 N MSE B 192 1555 1555 1.33 LINK C MSE B 192 N GLY B 193 1555 1555 1.33 LINK C VAL B 236 N MSE B 237 1555 1555 1.33 LINK C MSE B 237 N ALA B 238 1555 1555 1.33 LINK C TYR B 264 N MSE B 265 1555 1555 1.33 LINK C MSE B 265 N PRO B 266 1555 1555 1.34 LINK C HIS B 286 N MSE B 287 1555 1555 1.33 LINK C MSE B 287 N ARG B 288 1555 1555 1.33 LINK C GLN B 341 N TPO B 342 1555 1555 1.33 LINK C TPO B 342 N VAL B 343 1555 1555 1.33 LINK C VAL B 343 N MSE B 344 1555 1555 1.33 LINK C MSE B 344 N TPO B 345 1555 1555 1.33 LINK C TPO B 345 N SER B 346 1555 1555 1.33 LINK C TYR B 354 N MSE B 355 1555 1555 1.33 LINK C MSE B 355 N ALA B 356 1555 1555 1.33 LINK C LYS B 417 N MSE B 418 1555 1555 1.32 LINK C MSE B 418 N ASN B 419 1555 1555 1.32 LINK C ALA B 428 N MSE B 429 1555 1555 1.34 LINK C MSE B 429 N TYR B 430 1555 1555 1.33 LINK C GLU B 456 N MSE B 457 1555 1555 1.32 LINK C MSE B 457 N THR B 458 1555 1555 1.33 CISPEP 1 GLU A 392 PRO A 393 0 0.14 CISPEP 2 GLU B 392 PRO B 393 0 -0.11 CRYST1 90.150 118.640 140.710 90.00 90.00 90.00 I 2 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011093 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008429 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007107 0.00000